"
Team:Ehime-Japan/Safety
From 2012.igem.org
| Line 100: | Line 100: | ||
</ul> | </ul> | ||
</li> | </li> | ||
| - | <li><a href="#">Human | + | <li><a href="#">Human Practice</a> |
<ul> | <ul> | ||
| - | <li><a href="https://2012.igem.org/Team:Ehime-Japan/ | + | <li><a href="https://2012.igem.org/Team:Ehime-Japan/HumanPractice-E.create">E.create</a></li> |
| - | <li><a href="https://2012.igem.org/Team:Ehime-Japan/ | + | <li><a href="https://2012.igem.org/Team:Ehime-Japan/HumanPractice-Questionnaire">Questionnaire</a></li> |
</ul> | </ul> | ||
| Line 118: | Line 118: | ||
</li> | </li> | ||
</ul> | </ul> | ||
| + | |||
<br> | <br> | ||
<br> | <br> | ||
Revision as of 11:28, 26 September 2012
Safety
Q1
Would any of your project ideas raise safety issues in terms of researcher safety, public safety, or environmental safety?
A1
No. Our project ideas do not raise safety issues in terms of them. We are doing all experiments in the lab and disposition is carried out properly. Therefore, our project ideas are safe for researcher, public, or the environment.
Q2
Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes, did you document these issues in the Registry? How did you manage to handle the safety issue? How could other teams learn from your experience?
A2
No. Our new BioBrick parts are safe and all the genes we used are BL1 or BL2.
Q3
Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project? If no, which specific biosafety rules or guidelines do you have to consider in your country?
A3
Yes. Before we started the experiments, we submitted the safety list about our projects to our biosafety
committee, and it was accepted without problems.
Q4
Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
A4
We think it would be good to make a check list in order to confirm whether projects or experimental equipment are proper. Also, in case of using a virulent organism or a gene from it, the user should show clearly how to deal with it. We can easily answer and find some problems we did not think.
